HOPE Therapeutics™, Inc. ("HOPE"), a medical and technology driven company, and a wholly-owned subsidiary of NRx ...

InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Yair Malca, Chief Financial Officer will host investor meetings at the BTIG MedTech, ...

In a report released today, Clark Lampen from BTIG maintained a Buy rating on DraftKings (DKNG – Research Report), with a price target of ...

BTIG downgraded MGM Resorts (MGM) to Neutral from Buy ahead of the Q4 earnings report. The firm is optimistic around iGaming market expansion, ...

Research analysts at BTIG Research reduced their Q4 2025 earnings estimates for shares of D.R. Horton in a research note ...

BTIG analyst Lance Jessurun reaffirmed a Neutral rating on PayPal (NASDAQ:PYPL) stock, expressing caution ahead of the ...

The Company has recently announced execution of an agreement for $27 million in funding for HOPE <a target=_blank href= ...

BTIG analyst Mark Massaro announced an increased price target for IDEXX Laboratories (NASDAQ:IDXX), raising it from $500 to $530, while maintaining a Buy rating on the stock. The revision follows ...

Market technician Jonathan Krinsky analyzes the shift in market leadership from technology to healthcare amid recent ...

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions ...

Heck Capital Advisors LLC acquired a new position in shares of Regency Centers Co. (NASDAQ:REG – Free Report) in the 4th quarter, Holdings Channel.com reports. The firm acquired 357 shares of the ...

On Wednesday, BTIG analyst Carl Reichardt Jr. maintained a Neutral rating on shares of NVR Inc . (NYSE:NVR), while slightly lowering earnings per share (EPS) estimates for the upcoming years.